Cargando…

BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer

Triple-negative breast cancer (TNBC) is associated with poor clinical prognosis due to a lack of effective therapeutic options. The expression of B-cell lymphoma/leukemia 11A (BCL11A) has been indicated to correlate with TNBC carcinogenesis, though the precise mechanisms of BCL11A-induced tumorigene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xin, Xu, Yumei, Xu, Kun, Chen, Yajuan, Xiao, Xiudi, Guan, Xiaoxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068233/ https://www.ncbi.nlm.nih.gov/pubmed/32218847 http://dx.doi.org/10.3892/ol.2020.11383

Ejemplares similares

ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
por: Song, Wei, et al.
Publicado: (2017)

Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
por: Brumec, Maša, et al.
Publicado: (2021)

The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer
por: Luo, Jiayan, et al.
Publicado: (2016)

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
por: Lehmann, Brian D, et al.
Publicado: (2014)

PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer
por: Song, Wei, et al.
Publicado: (2017)

Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer
por: Song, Wei, et al.
Publicado: (2017)

Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features
por: Astvatsaturyan, Kristine, et al.
Publicado: (2018)

Therapeutic landscape in mutational triple negative breast cancer
por: Shi, Yaqin, et al.
Publicado: (2018)

BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells
por: Khaled, Walid T., et al.
Publicado: (2015)

SOX9 interacts with FOXC1 to activate MYC and regulate CDK7 inhibitor sensitivity in triple-negative breast cancer
por: Tang, Lin, et al.
Publicado: (2020)

The long non‐coding RNA landscape in triple‐negative breast cancer
por: Zhang, Wenwen, et al.
Publicado: (2020)

Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype
por: Angius, Andrea, et al.
Publicado: (2022)

The DNA repair function of BCL11A suppresses senescence and promotes continued proliferation of triple-negative breast cancer cells
por: Vickridge, Elise, et al.
Publicado: (2022)

Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis
por: Wang, Changjun, et al.
Publicado: (2016)

Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer
por: Khadela, Avinash, et al.
Publicado: (2022)

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2017)

Targeting the androgen receptor in triple-negative breast cancer: current perspectives
por: Mina, Alain, et al.
Publicado: (2017)

HC-1119, a deuterated Enzalutamide, inhibits Migration, Invasion and Metastasis of the AR-positive triple-negative breast Cancer cells
por: Wu, Xuehong, et al.
Publicado: (2022)

Correction to ‘The DNA repair function of BCL11A suppresses senescence and promotes continued proliferation of triple-negative breast cancer cells’
Publicado: (2023)

Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis
por: Zhang, Li, et al.
Publicado: (2015)

Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling
por: Cuenca-López, María D, et al.
Publicado: (2014)

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
por: Thakkar, A., et al.
Publicado: (2016)

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
por: Speers, Corey, et al.
Publicado: (2017)

Novel BH4-BCL-2 Domain Antagonists Induce BCL-2-Mediated Apoptosis in Triple-Negative Breast Cancer
por: Kanakaveti, Vishnupriya, et al.
Publicado: (2022)

BCL11B is required for positive selection and survival of double-positive thymocytes
por: Albu, Diana I., et al.
Publicado: (2007)

GROα overexpression drives cell migration and invasion in triple negative breast cancer cells
por: Bhat, Kruttika, et al.
Publicado: (2017)

Inhibition of miR-214 attenuates the migration and invasion of triple-negative breast cancer cells
por: Zhang, Yi, et al.
Publicado: (2019)

CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasion
por: Fan, Long, et al.
Publicado: (2017)

Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin
por: Inao, Touko, et al.
Publicado: (2018)

Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly
por: Giovannelli, Pia, et al.
Publicado: (2019)

Triple-negative and triple-positive breast cancer cells reciprocally control their growth and migration via the S100A4 pathway
por: Dukhanina, Elena A., et al.
Publicado: (2022)

Roles of MALAT1 in development and migration of triple negative and Her-2 positive breast cancer
por: Xiping, Zhang, et al.
Publicado: (2017)

Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer
por: Li, Xintong, et al.
Publicado: (2022)

Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells
por: Liu, Chun-Yu, et al.
Publicado: (2017)

Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer
por: Lee, Reeree, et al.
Publicado: (2022)

Clinicopathological features and androgen receptor expression in triple negative breast cancer at Lagos, Nigeria
por: Haruna, Muibat, et al.
Publicado: (2022)

Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
por: Dubrava, Alex L, et al.
Publicado: (2023)

Bcl11a is essential for lymphoid development and negatively regulates p53
por: Yu, Yong, et al.
Publicado: (2012)

C/EBPβ isoform-specific regulation of migration and invasion in triple-negative breast cancer cells
por: Sterken, Britt A., et al.
Publicado: (2022)

The expression of Rab5 and its effect on invasion, migration and exosome secretion in triple negative breast cancer
por: Qiao, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_np4kn2u2cia90bgk1l8ub6dfhr